Zai Lab Limited ZLAB
21.96 USD +0.30 (+1.36%)
At closeNov 3, 2026, 4:16 PM EST
22.10 +0.14 +0.64%
After hours · Nov 3, 4:16 PM ET
21.42 Day range 22.28
15.96 52-week range 27.50
- YTD
- +24.49%
- 1 year
- -17.91%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 33.48 +52.4% upside
Now 21.96
- Target (low)
- 24.25
- Target (mean)
- 33.48
- Target (high)
- 50.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
- Strong buy2
- Buy8
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 12
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.59177 | -0.66613 – -0.50308 | -0.33 | -79.3% | 107.89M | -7.1% | 6 |
| Next quarter | -0.63721 | -1.03 – -0.48529 | -0.46 | -38.5% | 112.46M | -11.9% | 6 |
| Current year | -2.20 | -2.76 – -1.60 | -1.60 | -37.2% | 431.77M | -6.2% | 10 |
| Next year | -2.10 | -3.15 – -1.17 | -2.20 | +4.5% | 547.22M | +26.7% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | Citigroup | Maintained | Buy | Buy |
| May 8, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 18, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 27, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Feb 5, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 7, 2026 | UBS | Initiated | — | Buy |
| Aug 11, 2025 | Citigroup | Maintained | Buy | Buy |
| Jun 30, 2025 | Leerink Partners | Maintained | Outperform | Outperform |
| Mar 27, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 13, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 7, 2025 | Scotiabank | Initiated | — | Sector Outperform |
| Mar 3, 2025 | B of A Securities | Downgrade | Buy | Neutral |
| Oct 25, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Oct 21, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 7, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jul 12, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 1, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jun 25, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Feb 29, 2024 | Citigroup | Maintained | Buy | Buy |
| Dec 14, 2023 | Morgan Stanley | Initiated | — | Overweight |
| Nov 30, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 26, 2023 | Citigroup | Maintained | Buy | Buy |
| Oct 26, 2023 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 17, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 9, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 18, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 10, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 12, 2023 | B of A Securities | Maintained | — | Buy |
| May 11, 2023 | Citigroup | Maintained | Buy | Buy |
| Mar 16, 2023 | JP Morgan | Maintained | — | Overweight |